The stock's fall snapped a four-day winning streak.

On May 21, analyst Geoff Meacham of Citi maintained a Hold rating on Pfizer Inc. (NYSE:PFE), reiterating the price target of ...

My monthly update and commentary on the top dividend stock picks from the Barron's Better Bets list, May 2025 edition. Read ...

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...